Abstract
Interstitial lung disease is a common complication of many of the connective tissue diseases. Because the prognosis, degree of reversibility, and optimal therapy differs for each disease presentation, a thorough knowledge of the pulmonary presentations of each connective tissue disease is important. Additionally, the challenge of finding the patient who has occult connective tissue disease in an interstitial lung disease clinic is discussed.
MeSH terms
-
Arthritis, Rheumatoid / epidemiology
-
Comorbidity
-
Connective Tissue Diseases / diagnosis
-
Connective Tissue Diseases / epidemiology*
-
Cyclophosphamide / therapeutic use
-
Dermatomyositis / epidemiology
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Lung Diseases, Interstitial / drug therapy
-
Lung Diseases, Interstitial / epidemiology*
-
Lupus Erythematosus, Systemic / epidemiology
-
Physical Examination
-
Pneumonia / epidemiology
-
Scleroderma, Systemic / epidemiology
Substances
-
Immunosuppressive Agents
-
Cyclophosphamide